<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Marijuana Inc. — News on 6ix</title>
<link>https://6ix.com/company/marijuana-inc</link>
<description>Latest news and press releases for Marijuana Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 07 Apr 2026 14:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/marijuana-inc" rel="self" type="application/rss+xml" />
<item>
<title>NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test</title>
<link>https://6ix.com/company/marijuana-inc/news/nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test</guid>
<pubDate>Tue, 07 Apr 2026 14:30:00 GMT</pubDate>
<description>ORLANDO, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is proud to announce the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market. NexTel will begin the distribution of test kits this week to initiate the collection of essential control samples. These samples serve as the foundationa</description>
</item>
<item>
<title>Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-favorable-litigation-settlement-highlighting-significant-debt-elimination-and-share-cancellation-to-enhance-shareholder-value</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-favorable-litigation-settlement-highlighting-significant-debt-elimination-and-share-cancellation-to-enhance-shareholder-value</guid>
<pubDate>Mon, 16 Mar 2026 14:15:00 GMT</pubDate>
<description>ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance shee</description>
</item>
<item>
<title>Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-strategic-elimination-of-future-dilutive-issuance-of-47-million-shares-progresses-toward-definitive-agreements-for-telehealth-acquisitions-11</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-strategic-elimination-of-future-dilutive-issuance-of-47-million-shares-progresses-toward-definitive-agreements-for-telehealth-acquisitions-11</guid>
<pubDate>Thu, 05 Mar 2026 18:00:00 GMT</pubDate>
<description>ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce several pivotal corporate milestones aimed at enhancing shareholder value and expanding the company’s commercial footprint. Major Capital Structure Optimization Exousia Pro has successfully completed the cancellation of derivative securities convertible into 47 million shares of Common Stock. Th</description>
</item>
<item>
<title>Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-accelerates-strategic-expansion-with-third-telehealth-acquisition-strengthens-pathway-to-low-cost-customer-acquisition</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-accelerates-strategic-expansion-with-third-telehealth-acquisition-strengthens-pathway-to-low-cost-customer-acquisition</guid>
<pubDate>Tue, 10 Feb 2026 15:30:00 GMT</pubDate>
<description>Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition.</description>
</item>
<item>
<title>Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-executed-loi-for-strategic-acquisition-of-high-revenue-telehealth-platform-to-accelerate-nutraceutical-commercialization</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-announces-executed-loi-for-strategic-acquisition-of-high-revenue-telehealth-platform-to-accelerate-nutraceutical-commercialization</guid>
<pubDate>Thu, 11 Dec 2025 17:15:00 GMT</pubDate>
<description>Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization.</description>
</item>
<item>
<title>Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-revolutionizes-nutraceuticals-with-launch-of-maxasometm-the-first-all-natural-biologically-active-exosomal-supplement</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-revolutionizes-nutraceuticals-with-launch-of-maxasometm-the-first-all-natural-biologically-active-exosomal-supplement</guid>
<pubDate>Fri, 05 Dec 2025 16:00:00 GMT</pubDate>
<description>Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement.</description>
</item>
<item>
<title>Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-completes-exclusive-licensing-agreement-with-the-university-of-central-florida-for-novel-cancer-diagnostic-and-therapy-platforms</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-inc-completes-exclusive-licensing-agreement-with-the-university-of-central-florida-for-novel-cancer-diagnostic-and-therapy-platforms</guid>
<pubDate>Tue, 02 Dec 2025 18:45:00 GMT</pubDate>
<description>Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms.</description>
</item>
<item>
<title>Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-initiates-strategic-realignment-acquires-controlling-stake-in-sec-reporter-lamy-lmmy-in-all-stock-exchange-transaction-for-exousia-ai-to-advance-growth-and-enhance-shareholder-value</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-initiates-strategic-realignment-acquires-controlling-stake-in-sec-reporter-lamy-lmmy-in-all-stock-exchange-transaction-for-exousia-ai-to-advance-growth-and-enhance-shareholder-value</guid>
<pubDate>Mon, 17 Nov 2025 20:40:00 GMT</pubDate>
<description>Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value.</description>
</item>
<item>
<title>Exousia Pro Announces Breakthrough In Exosome-Based Delivery</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-breakthrough-in-exosome-based-delivery</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-breakthrough-in-exosome-based-delivery</guid>
<pubDate>Tue, 04 Nov 2025 15:40:00 GMT</pubDate>
<description>Exousia Pro Announces Breakthrough In Exosome-Based Delivery.</description>
</item>
<item>
<title>Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-is-excited-to-announce-that-it-has-received-orphan-drug-designation-from-the-fda</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-is-excited-to-announce-that-it-has-received-orphan-drug-designation-from-the-fda</guid>
<pubDate>Tue, 28 Oct 2025 14:20:00 GMT</pubDate>
<description>Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA.</description>
</item>
<item>
<title>Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-groundbreaking-study-to-revolutionize-the-global-edibles-market-with-cbd-loaded-exosomes</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-groundbreaking-study-to-revolutionize-the-global-edibles-market-with-cbd-loaded-exosomes</guid>
<pubDate>Mon, 29 Sep 2025 16:35:00 GMT</pubDate>
<description>Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes.</description>
</item>
<item>
<title>Exousia Pro Reports Positive Outcome in Legal Proceeding</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-reports-positive-outcome-in-legal-proceeding</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-reports-positive-outcome-in-legal-proceeding</guid>
<pubDate>Fri, 26 Sep 2025 14:30:00 GMT</pubDate>
<description>Exousia Pro Reports Positive Outcome in Legal Proceeding.</description>
</item>
<item>
<title>Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-files-provisional-patent-for-novel-extracellular-vesicle-loading-method-tapping-into-multi-billion-dollar-markets</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-files-provisional-patent-for-novel-extracellular-vesicle-loading-method-tapping-into-multi-billion-dollar-markets</guid>
<pubDate>Wed, 10 Sep 2025 14:30:00 GMT</pubDate>
<description>Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets.</description>
</item>
<item>
<title>Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-strategic-acquisition-to-launch-a-new-telehealth-division</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-announces-strategic-acquisition-to-launch-a-new-telehealth-division</guid>
<pubDate>Mon, 08 Sep 2025 19:15:00 GMT</pubDate>
<description>Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division.</description>
</item>
<item>
<title>Exousia Pro Creates New Subdivisions</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-creates-new-subdivisions</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-creates-new-subdivisions</guid>
<pubDate>Wed, 03 Sep 2025 13:45:00 GMT</pubDate>
<description>Exousia Pro Creates New Subdivisions.</description>
</item>
<item>
<title>Exousia Pro Files Reg A.</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-files-reg-a</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-files-reg-a</guid>
<pubDate>Wed, 25 Jun 2025 15:35:00 GMT</pubDate>
<description>Exousia Pro Files Reg A..</description>
</item>
<item>
<title>Exousia Pro Expands its Scientific Advisory Board</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-expands-its-scientific-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-expands-its-scientific-advisory-board</guid>
<pubDate>Wed, 18 Jun 2025 15:30:00 GMT</pubDate>
<description>Exousia Pro Expands its Scientific Advisory Board.</description>
</item>
<item>
<title>Exousia Pro Will Launch a Web Series with Our New Consultant</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-will-launch-a-web-series-with-our-new-consultant</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-will-launch-a-web-series-with-our-new-consultant</guid>
<pubDate>Wed, 30 Apr 2025 13:30:00 GMT</pubDate>
<description>Exousia Pro Will Launch a Web Series with Our New Consultant.</description>
</item>
<item>
<title>Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-finishes-preclinical-trial-for-glioblastoma-ahead-of-schedule-bolstering-orphan-drug-application</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-finishes-preclinical-trial-for-glioblastoma-ahead-of-schedule-bolstering-orphan-drug-application</guid>
<pubDate>Tue, 29 Apr 2025 15:30:00 GMT</pubDate>
<description>Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application.</description>
</item>
<item>
<title>Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview</title>
<link>https://6ix.com/company/marijuana-inc/news/exousia-pro-cso-revealed-significant-findings-about-the-glioblastoma-study-in-a-spaces-interview</link>
<guid isPermaLink="true">https://6ix.com/company/marijuana-inc/news/exousia-pro-cso-revealed-significant-findings-about-the-glioblastoma-study-in-a-spaces-interview</guid>
<pubDate>Mon, 21 Apr 2025 15:47:57 GMT</pubDate>
<description>Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview.</description>
</item>
</channel>
</rss>